Table 2

Ability of HbA1c, FPG and RPG to define suboptimal glucose control using CGM thresholds <8 and <10 mmol/L

CGM cut-offTestNAUROC
(95% CI)
Optimal thresholdSensitivity
(95% CI)
Specificity
(95% CI)
Correctly classifiedPPV
(95% CI)
NPV
(95% CI)
≥8.0HbA1c1910.95
(0.92 to 0.98)
≥62 mmol/mol90.2
(83.1 to 95.0)
83.5
(73.5 to 90.9)
87.488.6
(81.3 to 93.8)
85.7
(75.9 to 92.6)
FPG1910.90
(0.86 to 0.95)
≥7.6 mmol/l84.8
(76.8 to 90.9)
81.0
(70.6 to 89.0)
83.386.4
(78.5 to 92.2)
79.0
(68.5 to 87.3)
RPG1920.82
(0.77 to 0.88)
≥11.6 mmol/l78.6
(69.8 to 85.8)
64.6
(53.0 to 75.0)
72.875.9
(67.0 to 83.3)
68.0
(56.2 to 78.3)
≥10.0HbA1c1910.94
(0.90 to 0.97)
≥72 mmol/mol88.9
(79.3 to 95.1)
84.9
(77.2 to 90.8)
86.478.0
(67.5 to 86.4)
92.7
(86.0 to 96.8)
FPG1910.90
(0.85 to 0.95)
≥9.1 mmol/l83.6
(73.0 to 91.2)
83.1
(75.0 to 89.3)
83.375.3
(64.5 to 84.2)
89.1
(81.7 to 94.2)
RPG1920.85
(0.79 to 0.91)
≥13.8 mmol/l84.7
(74.3 to 92.1)
72.3
(63.3 to 80.1)
77.064.9
(54.4 to 74.5)
88.7
(80.6 to 94.2)
  • The units used are as follows: HbA1c—mmol/mol and mmol/L for fasting and random non-fasting glucose.

  • AUROC, area under receiver operating characteristic curve; CGM, continuous glucose monitoring; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; NPV, negative predictive value; PPV, positive predictive value; RPG, random non-fasting plasma glucose.